Nanotechnology
Companies expand NanoCrystal technology license
Published in Drug Week, February 11th, 2005
The agreement will provide Roche with access to NanoCrystal technology and the right to apply it to a number of proprietary drug candidates.
Elan will receive development milestones and royalties on sales of any product incorporating the use of NanoCrystal technology.
Paul Breen, executive vice president, global services & operations, Elan, said, "We are very pleased to broaden our license agreement with Roche. This agreement highlights the robustness of the technology and the interest of pharmaceutical companies to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2005-02-11)
More Articles from Drug Week
- Drug Development
$210+ billion in market potential awaits nucleic acid therapeutics - Drug Development
Phase II study initiated for anti-obesity compound - Drug Development
Positive phase IIa data reported for Rambazole and Azoline in fungal infections - Drug Therapy
Influence of antipsychotic drugs studied, role of receptor antagonist revealed - Influenza Vaccine
Data from Vaxin's first flu vaccine clinical trial reported - Type 2 Diabetes
Data shows potential of arimoclomol as a therapeutic for type 2 diabetes - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
